These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8608133)

  • 1. Binding of phenylphosphocholine-carrier conjugates to the combining site of antibodies maintains a conformation of the hapten.
    Barbar E; Martin TM; Brown M; Rittenberg MB; Peyton DH
    Biochemistry; 1996 Mar; 35(9):2958-67. PubMed ID: 8608133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hapten conformation in the combining site of antibodies that bind phenylphosphocholine.
    Bruderer U; Peyton DH; Barbar E; Fellman JH; Rittenberg MB
    Biochemistry; 1992 Jan; 31(2):584-9. PubMed ID: 1731913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The primary structure and specificity determining residues displayed by recombinant salmon antibody domains.
    Solem ST; Brandsdal BO; Smalås A; Jørgensen TØ
    Mol Immunol; 2004 Apr; 40(18):1347-60. PubMed ID: 15072853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-directed mutagenesis and 1H nuclear magnetic resonance of an anti-dinitrophenyl spin label antibody.
    Martinez-Yamout M; McConnell HM
    J Mol Biol; 1994 Dec; 244(3):301-18. PubMed ID: 7966341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutational analysis of the binding of two different proteins to the same antibody.
    Dall'Acqua W; Goldman ER; Eisenstein E; Mariuzza RA
    Biochemistry; 1996 Jul; 35(30):9667-76. PubMed ID: 8703938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier-specificity of a phosphorylcholine-binding antibody requires the presence of the constant domains and is not dependent on the unique VH49 glycine or VH30 threonine residues.
    Tam FC; Ma CH; Leung DT; Sutton B; Lim PL
    J Immunol Methods; 2007 Apr; 321(1-2):152-63. PubMed ID: 17331532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of functionally important residues in the pyridoxal-5'-phosphate-dependent catalytic antibody 15A9.
    Mouratou B; Stetefeld J
    Biochemistry; 2004 Jun; 43(21):6612-9. PubMed ID: 15157094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a single-chain Fv fragment for the monitoring of deoxycholic acid residues anchored on endogenous proteins.
    Kobayashi N; Ohtoyo M; Wada E; Kato Y; Mano N; Goto J
    Steroids; 2005 Apr; 70(4):285-94. PubMed ID: 15784283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity labeling and topology of the antibody combining site.
    Givol D
    Essays Biochem; 1974; 10():73-103. PubMed ID: 4140089
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of different hapten-carrier conjugation ratios and molecular orientations on antibody affinity against a peptide antigen.
    Pedersen MK; Sorensen NS; Heegaard PM; Beyer NH; Bruun L
    J Immunol Methods; 2006 Apr; 311(1-2):198-206. PubMed ID: 16574142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermodynamics and kinetics of the reaction of a single-chain antibody fragment (scFv) with the leucine zipper domain of transcription factor GCN4.
    Weber-Bornhauser S; Eggenberger J; Jelesarov I; Bernard A; Berger C; Bosshard HR
    Biochemistry; 1998 Sep; 37(37):13011-20. PubMed ID: 9737882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A focused antibody library for improved hapten recognition.
    Persson H; Lantto J; Ohlin M
    J Mol Biol; 2006 Mar; 357(2):607-20. PubMed ID: 16445941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Cleavable" hapten-biotin conjugates: preparation and use for the generation of anti-steroid single-domain antibody fragments.
    Kobayashi N; Oyama H; Nakano M; Kanda T; Banzono E; Kato Y; Karibe T; Nishio T; Goto J
    Anal Biochem; 2009 Apr; 387(2):257-66. PubMed ID: 19454256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning, expression, and characterization of a single-domain antibody fragment with affinity for 15-acetyl-deoxynivalenol.
    Doyle PJ; Arbabi-Ghahroudi M; Gaudette N; Furzer G; Savard ME; Gleddie S; McLean MD; Mackenzie CR; Hall JC
    Mol Immunol; 2008 Aug; 45(14):3703-13. PubMed ID: 18632156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope mapping studies with human anti-cytochrome P450 3A antibodies.
    Leeder JS; Gaedigk A; Lu X; Cook VA
    Mol Pharmacol; 1996 Feb; 49(2):234-43. PubMed ID: 8632755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
    Thayer MM; Olender EH; Arvai AS; Koike CK; Canestrelli IL; Stewart JD; Benkovic SJ; Getzoff ED; Roberts VA
    J Mol Biol; 1999 Aug; 291(2):329-45. PubMed ID: 10438624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of llama single-domain antibodies against methotrexate, a prototypical hapten.
    Alvarez-Rueda N; Behar G; Ferré V; Pugnière M; Roquet F; Gastinel L; Jacquot C; Aubry J; Baty D; Barbet J; Birklé S
    Mol Immunol; 2007 Mar; 44(7):1680-90. PubMed ID: 17011035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody multispecificity mediated by conformational diversity.
    James LC; Roversi P; Tawfik DS
    Science; 2003 Feb; 299(5611):1362-7. PubMed ID: 12610298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody--hapten interactions in solution.
    Dwek RA; Jones R; Marsh D; McLaughlin AC; Press EM; Price NC; White AI
    Philos Trans R Soc Lond B Biol Sci; 1975 Nov; 272(915):53-74. PubMed ID: 1818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.